Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback